Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

Share Price is delayed by 15 minutes
Get Live Data
0.475    0.00 (0.00%)
Bid:
0.45
Ask:
0.50
Spread: 0.05 (11.111%)
Market Cap: £4.43m
SUN Live PriceLast checked at - London Stock Exchange

Intraday Surgical Innovations Share Chart

US Distribution Agreement

30 Jul 2007 07:01

Surgical Innovations Group PLC30 July 2007 Press Release - final 30 July 2007 Surgical Innovations Group plc ("SI" or "The Group") US Distribution Agreement Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer ofinnovative surgical devices, announces that it has signed a distributionagreement with MGM Med Inc. ("MGM"), a wholesale distributor of medical andhospital equipment, for the provision of its laparoscopic equipment to the USmarket. Under the terms of the agreement, MGM has the right to use the SurgicalInnovations ("SI") name and will promote the SI brand through its newly formedsubsidiary, Surgical Innovations US Inc. ("Surgical US"). Surgical US will become the master distributor of SI branded products in the USand will engage with new key channel partners including surgical procedural traycompanies, major medical distributors and small independent representatives thatservice more than 6,000 hospitals in the US market The agreement incorporates a minimum sales target of US$20 million, net to SI,over the five year term. The agreement has already led to the appointment by Surgical US of its firstchannel partner, Tri-anim Health Services, Inc. ("Tri-anim"), a leadingspecialty distributor of medical and hospital equipment in the US. Tri-animwill begin sales of SI's single use laparoscopic scissors from August 2007,initially in the south east of the US and increasing thereafter on a regionalbasis, eventually providing nationwide coverage. Mary Meyer, President and CEO of Surgical US, said: "The US market for singleuse scissors is currently valued at over US$125 million and we see hugepotential for SI products throughout the entire US laparoscopic equipmentmarket." Graham Bowland, Finance Director of Surgical Innovations Group plc, commented: "The creation by MGM of Surgical US provides new and exciting routes to marketfor SI's products, further expanding our presence within North America. The useof the Surgical Innovations trademark will increase our brand recognition acrossthe US and will support our strategy for future growth." - Ends - For further information:Surgical Innovations Group plcGraham Bowland, Finance Director Tel: +44 (0) 113 230 7597graham.bowland@surginno.co.uk www.sigroupplc.com Hanson Westhouse LimitedTim Feather / Matthew Johnson Tel: +44 (0) 113 246 2610tim.feather@hansonwesthouse.com www.hansonwesthouse.com Media enquiries:AbchurchGareth Mead / Justin Heath Tel: +44 (0) 20 7398 7700gareth.mead@abchurch-group.com www.abchurch-group.com Notes to Editors: Surgical Innovations Group plc specialises in the design and manufacture ofinnovative devices for use in minimally invasive surgery and industrial markets.The Group employs over 50 people and is headquartered in Leeds. The Group's medical division is focused on strong international growth in twospecialist areas namely minimally invasive surgery, where products are used in'keyhole' surgery which is more accurately known as laparoscopic surgery, andproducts for autologous blood transfusion whereby a patient's own blood isrecycled. The Group's industrial division utilises Surgical Innovations' core medicaldevice design expertise and technology in innovative engineering applications. For more information, see www.sigroupplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Jun 20267:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
21st Apr 20267:00 amRNSFinal Results
9th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Jan 20267:00 amRNSChief Financial Officer update
18th Dec 20257:00 amRNSTrading Update
28th Nov 20257:00 amRNSNew LTIP & Grant of Options
29th Sep 20257:05 amRNSBoard Changes
29th Sep 20257:00 amRNSHalf-year Report
17th Sep 20253:15 pmRNSNotice of Results
27th Jun 20254:42 pmRNSResult of AGM
26th Jun 202511:36 amRNSWithdrawal of AGM Resolutions 9 and 10
4th Jun 20258:00 amRNSNotice of AGM & Posting of Annual Report &Accounts
30th May 20257:00 amRNSFinal Results
10th Apr 20257:00 amRNSTrading update
1st Apr 202511:30 amRNSUpdate on timing of 2024 Full Year results
19th Feb 202510:11 amRNSHolding(s) in Company
17th Feb 20254:12 pmRNSHolding(s) in Company
12th Feb 20257:00 amRNSFY24 Trading Update & & Directorship Change
30th Sep 20247:00 amRNSHalf-year Report
10th Sep 20247:00 amRNSNotice of Results
27th Aug 20243:51 pmRNSHolding(s) in Company
27th Aug 20243:49 pmRNSHolding(s) in Company
19th Aug 20241:06 pmRNSHolding(s) in Company
19th Aug 20241:01 pmRNSHolding(s) in Company
29th Jul 202412:18 pmRNSHolding(s) in Company
25th Jul 20244:04 pmRNSHolding(s) in Company
17th Jun 20244:43 pmRNSResult of AGM
10th Jun 20247:00 amRNSDirectorate Change - Appointment of CFO
23rd May 20247:00 amRNSNotice of AGM and Posting of Annual Report
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.